DexCom Additional Paid-In Capital increased by 2.5% to $2.34B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.1%, from $2.14B to $2.34B. Over 5 years (FY 2020 to FY 2025), Additional Paid-In Capital shows an upward trend with a 5.7% CAGR.
An increase indicates equity financing or the issuance of shares for employee compensation, signaling capital raising or dilution.
This represents the excess amount paid by shareholders for common stock over its par value. It is a primary component of...
Standard equity account for all publicly traded companies.
equity_additional_paid_in_capital_common_stock| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.19B | $2.32B | $2.11B | $2.00B | $2.03B | $2.07B | $2.26B | $2.31B | $2.27B | $3.62B | $3.51B | $2.51B | $1.99B | $2.05B | $2.09B | $2.14B | $2.19B | $2.25B | $2.28B | $2.34B |
| QoQ Change | — | +5.9% | -9.2% | -5.3% | +1.6% | +2.1% | +9.0% | +2.1% | -1.6% | +59.5% | -2.9% | -28.6% | -20.6% | +2.9% | +2.1% | +2.3% | +2.1% | +2.7% | +1.6% | +2.5% |
| YoY Change | — | — | — | — | -7.5% | -10.8% | +7.1% | +15.5% | +11.8% | +74.6% | +55.6% | +8.9% | -12.2% | -43.3% | -40.4% | -14.7% | +9.8% | +9.6% | +9.0% | +9.1% |